Roche and Biogen Settle Patent Lawsuit Amid Biosimilar Market Growth
Pharmaceutical giants Hoffmann-La Roche Inc. and Biogen MA Inc. have reached a settlement in a patent lawsuit. Roche had alleged that Biogen’s proposed similar version of Roche’s rheumatoid arthritis drug, Actemra, infringed on several of its held patents. The details surrounding the settled lawsuit were laid out in a joint stipulation of dismissal filed earlier…